SCHEMBL25062874

SCHEMBL25062874

O=C(O)c1cc(NC2CCC2)cc(N2CCCCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.47
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 2/20 0.41
HCAR3 P49019 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GFER P55789 1/20 0.40
SYK P43405 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290478 1.00 GAA (0.47) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL23304283 0.87 MAPT (0.44) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL23304297 0.83 ALDH1A1 (0.42) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL5221612 0.79 NPC1 (0.56) GAAALDH1A1MEN1KMT2AHPGD
SCHEMBL5223517 0.77 NPC1 (0.54) GAAALDH1A1MEN1KMT2AHPGD
SCHEMBL732579 0.77 ALDH1A1 (0.67) GAAKDM4EALDH1A1MEN1KMT2A
SCHEMBL15054622 0.75 HCAR3 (0.45) GAAMEN1KMT2ALMNAHCAR3
SCHEMBL23304390 0.73 CHRM3 (0.54) ALDH1A1HPGDHCAR3POLB
SCHEMBL30290289 0.73 CHRM3 (0.54) ALDH1A1HPGDHCAR3POLB
SCHEMBL23684812 0.72 ALDH1A1 (0.43) ALDH1A1HSD17B10NPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054084-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230054084-A1 COMPOUNDS AND METHODS OF USE XDH, LPXN, F12 GAA 626/4885KDM4E 3468/4885ALDH1A1 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.